Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study

BACKGROUND: Singapore offered the BNT162b2 vaccine (tozinameran; Pfizer-BioNTech) to adolescents aged 12–17 years in May 18, 2021, and extended booster vaccines to this group in Jan 21, 2022. Literature on the effectiveness of primary series and booster vaccination among adolescents is scarce outsid...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiew, Calvin J, Premikha, M, Chong, Chia Yin, Wei, Wycliffe E, Ong, Benjamin, Lye, David Chien, Heng, Derrick, Lee, Vernon J, Tan, Kelvin Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519171/
https://www.ncbi.nlm.nih.gov/pubmed/36182678
http://dx.doi.org/10.1016/S1473-3099(22)00573-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519171/
https://www.ncbi.nlm.nih.gov/pubmed/36182678
http://dx.doi.org/10.1016/S1473-3099(22)00573-4

Ejemplares similares